Breaking News

Saturday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
U.S. TikTok, Tencent WeChat bans could be threat to Nasdaq rally, Barron's says » 10:35
08/08/20
08/08
10:35
08/08/20
10:35
TCEHY

Tencent

$0.00 /

+ (+0.00%)

, MSFT

Microsoft

$212.45 /

-3.87 (-1.79%)

, ATVI

Activision Blizzard

$82.50 /

-4.42 (-5.09%)

, UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

, SNAP

Snap

$21.58 /

+0.22 (+1.03%)

, SPOT

Spotify

$252.15 /

-3.205 (-1.26%)

, TSLA

Tesla

$1,452.81 /

-36.73 (-2.47%)

This past week, the White…

This past week, the White House opened a new front in the cold war fight with China by issuing executive orders banning U.S. companies from working with TikTok and Tencent's (TECHY) WeChat, Connor Smith writes in this week's edition of Barron's. The TikTok news wasn't a surprise as the Trump administration has target it for weeks, leading Microsoft (MSFT) to consider a purchase of TikTok's U.S. operations, but the Tencent news stunned investors, the author notes, adding that the news rippled through the videogame industry, where Tencent is a dominant force. The company owns Riot Games, publisher of League of Legends, and holds a 40% stake in Epic Games, publisher of Fortnite, and also has stakes in companies like Activision Blizzard (AVTI), Ubisoft (UBSFY), Snap (SNAP), Spotify (SPOT) and Tesla (TSLA). Reference Link

ShowHide Related Items >><<
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SPOT Spotify
$252.15 /

-3.205 (-1.26%)

SNAP Snap
$21.58 /

+0.22 (+1.03%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

08/05/20 Barclays
Activision Blizzard price target raised to $98 from $90 at Barclays
08/05/20 Morgan Stanley
Activision Blizzard price target raised to $100 from $88 at Morgan Stanley
08/05/20 UBS
Activision Blizzard price target raised to $106 from $84 at UBS
08/05/20 Oppenheimer
Activision Blizzard price target raised to $95 from $75 at Oppenheimer
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

07/23/20 JPMorgan
Ubisoft price target raised to EUR 82 from EUR 79 at JPMorgan
07/17/20 Oddo BHF
Ubisoft downgraded to Neutral from Buy at Oddo BHF
07/13/20 Jefferies
Ubisoft downgraded to Hold from Buy at Jefferies
07/13/20 Societe Generale
Ubisoft downgraded to Hold from Buy at Societe Generale
SNAP Snap
$21.58 /

+0.22 (+1.03%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/22/20
Fly Intel: Top five analyst downgrades
07/22/20 Oppenheimer
Snap price target raised to $28 from $18 at Oppenheimer
07/22/20 JPMorgan
Snap should be bought on any meaningful pullback, says JPMorgan
SPOT Spotify
$252.15 /

-3.205 (-1.26%)

07/30/20 Loop Capital
Spotify price target raised to $200 from $150 at Loop Capital
07/30/20 Deutsche Bank
Spotify price target raised to $240 from $144 at Deutsche Bank
07/27/20 Stifel
Spotify price target raised to $305 from $185 at Stifel
07/16/20 Credit Suisse
Spotify price target raised to $215 from $130 at Credit Suisse
TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

08/05/20 Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
07/28/20
Fly Intel: Top five analyst downgrades
07/28/20 Bernstein
Bernstein's Sacconaghi downgrades Tesla to sell on 'mind-boggling' valuation
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SPOT Spotify
$252.15 /

-3.205 (-1.26%)

SNAP Snap
$21.58 /

+0.22 (+1.03%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

  • 14
    Feb
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SPOT Spotify
$252.15 /

-3.205 (-1.26%)

SNAP Snap
$21.58 /

+0.22 (+1.03%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SPOT Spotify
$252.15 /

-3.205 (-1.26%)

SNAP Snap
$21.58 /

+0.22 (+1.03%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

TSLA Tesla
$1,452.81 /

-36.73 (-2.47%)

SPOT Spotify
$252.15 /

-3.205 (-1.26%)

SNAP Snap
$21.58 /

+0.22 (+1.03%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

ATVI Activision Blizzard
$82.50 /

-4.42 (-5.09%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

Friday
Downgrade
Livongo Health downgraded to Hold after Teledoc deal at Benchmark » 07:23
08/07/20
08/07
07:23
08/07/20
07:23
LVGO

Livongo Health

$134.29 /

+6.13 (+4.78%)

, TDOC

Teladoc

$212.75 /

+10.54 (+5.21%)

As previously reported,…

As previously reported, Benchmark analyst Bill Sutherland downgraded Livongo Health (LVGO) to Hold from Buy following the company's announcement of an agreement to be acquired by Teledoc (TDOC). He sees no substantial hurdles to the deal closing and has "trouble imagining a higher bid," Sutherland said.

ShowHide Related Items >><<
TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

08/07/20 Benchmark
Livongo Health downgraded to Hold from Buy at Benchmark
08/06/20 Deutsche Bank
Teladoc price target lowered to $225 from $238 at Deutsche Bank
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

  • 12
    Dec
TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

TDOC Teladoc
$212.75 /

+10.54 (+5.21%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

Downgrade
Livongo Health downgraded to Hold from Buy at Benchmark » 06:59
08/07/20
08/07
06:59
08/07/20
06:59
LVGO

Livongo Health

$134.29 /

+6.13 (+4.78%)

Benchmark analyst Bill…

Benchmark analyst Bill Sutherland downgraded Livongo Health to Hold from Buy.

ShowHide Related Items >><<
LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

08/06/20 Deutsche Bank
Teladoc price target lowered to $225 from $238 at Deutsche Bank
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/05/20 Stifel
Stifel views Teledoc, Livongo as largely complementary businesses
LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

  • 12
    Dec
LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

LVGO Livongo Health
$134.29 /

+6.13 (+4.78%)

Thursday
Earnings
BioLife Solutions reports Q2 non-GAAP EPS (1c), consensus (3c) » 16:39
08/06/20
08/06
16:39
08/06/20
16:39
BLFS

BioLife Solutions

$20.65 /

-0.35 (-1.67%)

Reports Q2 revenue $9.9M,…

Reports Q2 revenue $9.9M, consensus $9.57M. Mike Rice, CEO, commented, "We continued to advance the business during the second quarter, achieving record revenue and further adoption of our media, thaw, evo cold chain and freezer platforms. In the first half of 2020, we gained 88 new customers across the product portfolio. Significant institutional investor interest resulted in our completion of an oversubscribed public stock offering just after the close of the quarter. BioLife is very well positioned for both organic and additional acquisition driven growth."

ShowHide Related Items >><<
BLFS BioLife Solutions
$20.65 /

-0.35 (-1.67%)

BLFS BioLife Solutions
$20.65 /

-0.35 (-1.67%)

07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
07/08/20 Northland
BioLife Solutions price target raised to $28 from $24 at Northland
07/02/20 Lake Street
BioLife Solutions supplementing cash position 'makes sense,' says Lake Street
05/15/20 Stephens
BioLife Solutions price target raised to $24 after 'strong' Q1 beat at Stephens
BLFS BioLife Solutions
$20.65 /

-0.35 (-1.67%)

  • 02
    Jul
BLFS BioLife Solutions
$20.65 /

-0.35 (-1.67%)

Hot Stocks
Airlines rise as U.S. lifts global Level 4 health advisory for travel » 14:17
08/06/20
08/06
14:17
08/06/20
14:17
ALK

Alaska Air

$36.48 /

+0.74 (+2.07%)

, LUV

Southwest

$33.22 /

+0.52 (+1.59%)

, DAL

Delta Air Lines

$27.13 /

+0.64 (+2.42%)

, JBLU

JetBlue

$10.83 /

+0.085 (+0.79%)

, UAL

United Airlines

$34.62 /

+0.91 (+2.70%)

, SAVE

Spirit Airlines

$17.40 /

+0.24 (+1.40%)

, AAL

American Airlines

$13.22 /

+0.66 (+5.25%)

On August 6, in close…

On August 6, in close coordination with the U.S. Centers for Disease Control and Prevention, the Department of State lifted the Global Level 4 Health Advisory, the Department announced. "The Global Advisory, initially put in place on March 19, 2020, advised U.S. citizens to avoid all international travel due to the global impact of COVID-19. With health and safety conditions improving in some countries and potentially deteriorating in others, the Department is returning to our previous system of country-specific levels of travel advice (with Levels from 1-4 depending on country-specific conditions), in order to give travelers detailed and actionable information to make informed travel decisions. This will also provide U.S. citizens more detailed information about the current status in each country. We continue to recommend U.S. citizens exercise caution when traveling abroad due to the unpredictable nature of the pandemic." Publicly traded airlines include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL).

ShowHide Related Items >><<
UAL United Airlines
$34.62 /

+0.91 (+2.70%)

SAVE Spirit Airlines
$17.40 /

+0.24 (+1.40%)

LUV Southwest
$33.22 /

+0.52 (+1.59%)

JBLU JetBlue
$10.83 /

+0.085 (+0.79%)

DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

AAL American Airlines
$13.22 /

+0.66 (+5.25%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/29/20 Goldman Sachs
Alaska Air price target raised to $63 from $51 at Goldman Sachs
06/22/20 Raymond James
Alaska Air price target raised to $44 from $40 at Raymond James
06/16/20 Stifel
United loyalty deal raises odds of survival without restructuring, says Stifel
LUV Southwest
$33.22 /

+0.52 (+1.59%)

07/27/20 Raymond James
Southwest price target lowered to $42 from $45 at Raymond James
07/13/20 Wolfe Research
Southwest downgraded to Peer Perform from Outperform at Wolfe Research
07/13/20 Deutsche Bank
Southwest price target raised to $48 from $44 at Deutsche Bank
DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

06/29/20 Goldman Sachs
Delta Air Lines price target raised to $38 from $33 at Goldman Sachs
06/10/20 JPMorgan
Delta Air Lines price target lowered to $41 from $45 at JPMorgan
JBLU JetBlue
$10.83 /

+0.085 (+0.79%)

07/17/20 Seaport Global
JetBlue-American codeshare agreement a 'win-win,' says Seaport Global
06/29/20 Goldman Sachs
JetBlue price target raised to $17 from $12 at Goldman Sachs
06/17/20
Fly Intel: Top five analyst initiations
UAL United Airlines
$34.62 /

+0.91 (+2.70%)

06/29/20 Goldman Sachs
United Airlines price target raised to $61 from $40 at Goldman Sachs
06/17/20 Seaport Global
United Airlines initiated with a Buy at Seaport Global
SAVE Spirit Airlines
$17.40 /

+0.24 (+1.40%)

06/29/20 Goldman Sachs
Spirit Airlines price target raised to $20 from $15 at Goldman Sachs
06/17/20 Seaport Global
Spirit Airlines initiated with a Buy at Seaport Global
AAL American Airlines
$13.22 /

+0.66 (+5.25%)

07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Raymond James
American Airlines upgraded at Raymond James on balanced risk-reward
07/27/20 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
UAL United Airlines
$34.62 /

+0.91 (+2.70%)

SAVE Spirit Airlines
$17.40 /

+0.24 (+1.40%)

LUV Southwest
$33.22 /

+0.52 (+1.59%)

JBLU JetBlue
$10.83 /

+0.085 (+0.79%)

DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

AAL American Airlines
$13.22 /

+0.66 (+5.25%)

  • 23
    Jun
  • 08
    May
  • 29
    Apr
  • 22
    Apr
UAL United Airlines
$34.62 /

+0.91 (+2.70%)

LUV Southwest
$33.22 /

+0.52 (+1.59%)

DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

AAL American Airlines
$13.22 /

+0.66 (+5.25%)

UAL United Airlines
$34.62 /

+0.91 (+2.70%)

SAVE Spirit Airlines
$17.40 /

+0.24 (+1.40%)

LUV Southwest
$33.22 /

+0.52 (+1.59%)

JBLU JetBlue
$10.83 /

+0.085 (+0.79%)

DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

AAL American Airlines
$13.22 /

+0.66 (+5.25%)

UAL United Airlines
$34.62 /

+0.91 (+2.70%)

SAVE Spirit Airlines
$17.40 /

+0.24 (+1.40%)

LUV Southwest
$33.22 /

+0.52 (+1.59%)

JBLU JetBlue
$10.83 /

+0.085 (+0.79%)

DAL Delta Air Lines
$27.13 /

+0.64 (+2.42%)

ALK Alaska Air
$36.48 /

+0.74 (+2.07%)

AAL American Airlines
$13.22 /

+0.66 (+5.25%)

Hot Stocks
Greenlight Capital's Einhorn: Tesla short detracted from performance in Q2  09:12
08/06/20
08/06
09:12
08/06/20
09:12
GLRE

Greenlight Capital Re

$6.89 /

+0.25 (+3.77%)

, TSLA

Tesla

$1,485.80 /

-0.46 (-0.03%)

 
ShowHide Related Items >><<
TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

GLRE Greenlight Capital Re
$6.89 /

+0.25 (+3.77%)

GLRE Greenlight Capital Re
$6.89 /

+0.25 (+3.77%)

TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

08/05/20 Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
07/28/20
Fly Intel: Top five analyst downgrades
07/28/20 Bernstein
Bernstein's Sacconaghi downgrades Tesla to sell on 'mind-boggling' valuation
TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

GLRE Greenlight Capital Re
$6.89 /

+0.25 (+3.77%)

  • 14
    Feb
TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

GLRE Greenlight Capital Re
$6.89 /

+0.25 (+3.77%)

TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

TSLA Tesla
$1,485.80 /

-0.46 (-0.03%)

Recommendations
Nu Skin price target raised to $57 from $50 at Jefferies » 08:38
08/06/20
08/06
08:38
08/06/20
08:38
NUS

Nu Skin

$47.39 /

+1.37 (+2.98%)

Jefferies analyst…

Jefferies analyst Stephanie Wissink raised the firm's price target on Nu Skin to $57 from $50 and keeps a Buy rating on the shares. The company's Q2 sales were slightly ahead of the early-July pre-announcement, but the "standout measure" was total customers reaching an all-time high, Wissink tells investors. She sees Nu Skin's reduced dependence on China and robust growth in North America and EMEA as "especially encouraging," the analyst added.

ShowHide Related Items >><<
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

08/06/20 DA Davidson
Nu Skin price target raised to $61 from $54 at DA Davidson
08/06/20 Deutsche Bank
Nu Skin price target raised to $49 from $35 at Deutsche Bank
07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

Recommendations
Nu Skin price target raised to $61 from $54 at DA Davidson » 08:01
08/06/20
08/06
08:01
08/06/20
08:01
NUS

Nu Skin

$47.39 /

+1.37 (+2.98%)

DA Davidson analyst Linda…

DA Davidson analyst Linda Bolton Weiser raised the firm's price target on Nu Skin to $61 from $54 and keeps a Buy rating on the shares after its Q2 results and Q3 guidance. The company's sales growth is improving thanks to its socially enabled business model, the management's investments in technology, as well as Nu Skin's balanced product portfolio, the analyst tells investors in her research note.

ShowHide Related Items >><<
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

08/06/20 Deutsche Bank
Nu Skin price target raised to $49 from $35 at Deutsche Bank
07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

Recommendations
Nu Skin price target raised to $49 from $35 at Deutsche Bank » 07:49
08/06/20
08/06
07:49
08/06/20
07:49
NUS

Nu Skin

$47.39 /

+1.37 (+2.98%)

Deutsche Bank analyst…

Deutsche Bank analyst Faiza Alwy raised the firm's price target on Nu Skin Enterprises to $49 from $35 and keeps a Hold rating on the shares. The analyst was surprised by the Q2 revenue upside on the strength of social selling in the U.S. and Europe amidst lockdown conditions.

ShowHide Related Items >><<
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 DA Davidson
Nu Skin upgraded to Buy from Neutral at DA Davidson
07/02/20 Jefferies
Jefferies upgrades Nu Skin to Buy, sees 15%-20% share upside
NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

NUS Nu Skin
$47.39 /

+1.37 (+2.98%)

Recommendations
Teladoc price target lowered to $225 from $238 at Deutsche Bank » 07:41
08/06/20
08/06
07:41
08/06/20
07:41
TDOC

Teladoc

$202.21 /

-46.9 (-18.83%)

, LVGO

Livongo Health

$128.16 /

-16.32 (-11.30%)

Deutsche Bank analyst…

Deutsche Bank analyst George Hill lowered the firm's price target on Teladoc Health (TDOC) to $225 from $238 and keeps a Buy rating on the shares after the company announced a merger with Livongo Health (LVGO). The analyst views Livongo as a "compelling asset and a strong strategic fit" but admits the multiple paid is "eye watering."

ShowHide Related Items >><<
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
08/05/20 Stifel
Stifel views Teledoc, Livongo as largely complementary businesses
LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/05/20 JPMorgan
JPMorgan views combination with Livongo as positive for Teladoc
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

  • 12
    Dec
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.